DBHA

Operating Instructions (The following is a recommended experimental protocol for guidance only, and adjustments are required based on your specific needs)

1. Stock Solution Preparation
1.1 Solvent: DMSO.
1.2 Recommended concentration: 5 mM.

2. Working Solution Preparation
2.1 Diluent: 0.1 M sodium phosphate buffer (pH 8.6).
2.2 Working concentrations: 1 μM, 5 mM.
2.3 Notes: Adjust the working solution concentration as needed; prepare fresh before use.

3. Staining Procedure
3.1 For protein samples (bovine Cu/Zn superoxide dismutase)^[1]:
3.1.1 Incubation conditions:
3.1.1.1 Protein labeling: Mix 5 mM SOD solution, 5 mM DBHA (5 equivalents), and catalyst/ligand solution (final concentrations: 40 μM Pd (OAc)₂, 0.48 mM TPPTS) in 0.1 M sodium phosphate buffer (pH 8.6); incubate at 25°C for 1 h.
3.1.1.2 Acid effect analysis: Place 1 μM DBHA-labeled SOD in a solution adjusted to pH 2-9, and incubate at room temperature for 1 h.
3.1.1.3 Thermal effect analysis: Incubate 1 μM DBHA-labeled SOD at 70°C for 1-3 h.
3.1.1.4 Binding assay: Mix 10 μM DBHA with 5 μM SOD in 0.1 M sodium phosphate buffer (pH 8.6); incubate at room temperature for 30 min, with an optional additional heating at 70°C for 30-60 min.
3.1.2 Washing step: To purify the labeled protein, load the reaction mixture onto a Sephadex G-25 gel column, using 0.1 M sodium phosphate buffer (pH 8.6) as the eluent; collect protein fractions by monitoring absorbance at 258 nm.

4. Control Setup
4.1 For protein labeling assays, set up parallel control reactions without the Pd (OAc)₂/TPPTS catalyst/ligand solution.
4.2 For activity detection assays, set up parallel control reactions without SOD.
4.3 For specificity control, pretreat the proteome with soluble hydroxylamine or under acidic conditions (pH 2) to inhibit DBHA labeling.

5. Detection and Analysis
5.1 Instrument type: Fluorescence spectrophotometer.
5.2 Excitation/emission wavelengths:
5.2.1 DBHA in aqueous solution: λex = 585 nm, λem = 650 nm.
5.2.2 DBHA-labeled SOD: λex = 530 nm, λem = 608 nm.
5.2.3 DBHA in organic solvents: λex ranges from 517-547 nm, λem ranges from 584-628 nm.
5.3 Result analysis:
5.3.1 Fluorescence-based analysis:
5.3.1.1 Fluorescence intensity change: An increase in fluorescence intensity is observed when DBHA binds to a hydrophobic environment (such as a protein domain or denatured protein aggregate); the fluorescence intensity of DBHA increases as pH rises from 2 to 5, and then reaches a plateau.
5.3.1.2 Fluorescence wavelength shift: DBHA exhibits a blue shift in emission wavelength in less polar environments; the blue shift from 650 nm in aqueous solution to 608 nm in the Tyr108 domain of native SOD indicates a low-polarity environment around Tyr108; a further blue shift to 595 nm under pH 2-4 conditions or to 579 nm after 3 h of thermal denaturation indicates increased hydrophobicity of the Tyr108 domain; a 56 nm blue shift (from 650 nm to 594 nm) is observed when DBHA binds to thermally denatured SOD.
5.3.1.3 Fluorescence localization: After specific labeling, DBHA localizes at the Tyr108 residue of SOD.
5.3.1.4 Aggregation analysis: An increase in 90° light scattering intensity indicates protein aggregation during thermal denaturation.
5.3.1.5 Activity analysis: DBHA-labeled SOD retains approximately 95% of the activity of native SOD, as determined by monitoring absorbance at 550 nm using the xanthine oxidase/hydroxylamine method.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.